NA Proactive news snapshot: Globex Mining, Karora Resources, Alchemist Mining, Vuzix, Gevo UPDATE ...

Globex Mining Enterprises Inc (TSE:GMX) (OTCQX:GLBXF) said that drilling on a property on which it holds a royalty has intercepted high-grade gold intercepts of up 45.9 grams per ton gold over 2.1 metres. The intercept comes from the Kewagama gold mine portion of the O’Brien project operated by Radisson Mining Resources (CVE:RDS) (OTCMKTS:RMRDF), on which Globex holds a 2% net smelter royalty. The results represent a potential third high-grade mineralized trend, 900 metres east of the O’Brien Mine, according to the Quebec-based property bank. Karora Resources Inc (TSE:KRR) said Thursday it closed a previously announced agreement with Maverix Metals Inc to reduce the gold royalty at the firm’s flagship Beta Hunt mine in Australia from 7.5% to 4.75%. Karora agreed to pay Maverix US$18 million in cash, US$15.5 million of which was paid at closing and US$2.5 million of which will be paid in January 2021. In a statement, CEO Paul Andre Huet said: "Having now materially reduced the royalty burden at Beta Hunt, we are excited to move forward with our exploration program underground. This transaction has the potential to unlock significant value for both Karora and Maverix shareholders by allowing our strong operational team to develop Beta Hunt to its full potential.” Alchemist Mining Inc (CSE:AMS) announced Thursday that it has entered a non-binding letter of intent (LOI) for the acquisition of All Nations Cannabis Corporation, which is in the final stages of receiving a Health Canada license for the cultivation and processing of cannabis and associated products. In a statement, Alchemist said the transaction will include $20 million of real estate on First Nations territory, including a built-out late stage 30,000 square-foot cultivation facility on 14 acres of leased land with another six buildings on individual parcels of leased property. The proposed deal under the LOI also calls for the issuance of $20 million worth of Alchemist common shares at $0.045 each. In other news, the company announced a non-brokered private placement of common shares for gross proceeds of up to $3 million at $0.035 each. Vuzix Corporation (NASDAQ:VUZI), a supplier of smart glasses and augmented reality technology, has signed an agreement with a major international defense contractor to build a customized waveguide solution. Vuzix and its client agreed upon an upfront fee in addition to phase-gated development milestones and payments, the company said. Phase 1 of the agreement is expected to generate non-recurring engineering (NRE) revenue over the next three months, and potential for greater NREs exists in subsequent phases. Two future phases are currently contemplated, the company said, before an accepted final product design could be expected to lead to a volume production order. This represents the third active defense engineering program for Vuzix in 2020. Gevo Inc (NASDAQ:GEVO) announced Thursday that it has received a letter from The NASDAQ Stock Market LLC, saying that the company has regained compliance with the NASDAQ Capital Market’s minimum bid price continued listing requirement. Gevo said the letter noted that as of September 2, the closing bid price of its common stock traded in excess of the $1 minimum requirement for at least 10 consecutive trading days. Colorado-based Gevo is a next-generation “low-carbon” fuel company focused on the development and commercialization of renewable alternatives to petroleum-based products. First Cobalt Corp (CVE:FCC) (OTCMKTS:FTSSF) is quickly building the only permitted cobalt refinery in North America, a distinction that has earned the junior company a Buy rating from research house Red Cloud Securities. The Toronto-based company recently closed a C$2.5 million financing to develop its planned cobalt refinery in the aptly-named town of Cobalt, Ontario, with flow-through funds earmarked for exploration on its silver properties in the nearby Cobalt Camp. In an update earlier this week, Red Cloud said it is raising its price target on the stock by five cents to C$0.35 off the back of the firm’s successful financing. Avalon GloboCare Corp (NASDAQ:AVCO) announced Thursday the launch of its new allogeneic mesenchymal stromal cell (MSC) therapeutic platform as a potential therapy for the coronavirus (COVID-19) which is caused by the SARS-CoV-2 virus. In addition to being a potential therapy for COVID-19, the company said the platform will also be developed to treat bone marrow transplant-related complications of acute graft versus host disease (aGVHD). The company said it is currently progressing its planned pre-clinical testing for its MSC platform for COVID-19 and aGVHD, with plans to initiate a first-in-human clinical study during the first half of 2021, assuming clearance from the US and/or non-US regulatory agencies. Vuzix Corporation (NASDAQ:VUZI), a supplier of smart glasses and augmented reality technology, has signed an agreement with a major international defense contractor to build a customized waveguide solution. Vuzix and its client agreed upon an upfront fee in addition to phase-gated development milestones and payments, the company said. Phase 1 of the agreement is expected to generate non-recurring engineering (NRE) revenue over the next three months, and potential for greater NREs exists in subsequent phases. This represents the third active defense engineering program for Vuzix in 2020. NexTech AR Solutions Corp (CSE:NTAR) (OTCQB:NEXCF) announced Thursday that the Technology Association of Georgia (TAG) Digital Health has chosen the company’s InfernoAR video conferencing platform for its upcoming virtual event on November 1. The initial event will pay NexTech C$50,000, in addition to sponsorship opportunities with virtual booths and augmented reality (AR). TAG Digital Health is a member of the larger Technology Association of Georgia. TAG as a whole holds more than 150 events annually, which presents opportunities for additional deals. First Mining Gold Corp (TSE:FF) (OTCQX:FFMGF) revealed that its partner at the Pickle Crow gold project in Ontario has increased the scope of its current drill program to 45,000 metres (m) from 10,000m to boost efforts to expand the resource there. Auteco Minerals, which can earn up to 80% of the asset, currently has two diamond drill rigs turning with a third expected to be mobilized in late September following initial observations, First Mining said in a statement. So far, around 4,500 metres have been completed. Bragg Gaming Group Inc (CVE:BRAG) (OTCMKTS:BRGGF) said Thursday that its subsidiary ORYX Gaming has taken its content live into Denmark for the first time with several casino brands powered by SkillOnNet. SkillOnNet is a leading software platform provider which powers several popular online casino brands licensed in Denmark, including PlayOJO, LuckyVegas, SlotsMagic and RoyalBet. SkillOnNet’s casinos and operator partners will also enjoy access to ORYX’s advanced marketing tools, such as leaderboards and tournaments, that have been successful in improving acquisition and retention rates. In a statement, Matevz Mazij, who is a managing director at ORYX Gaming said: “Going live in Denmark is exciting for us and we are certain that our wide-ranging portfolio of casino content offers a perfect mix of classic and innovative titles that will fit the Danish players well.” Valeo Pharma Inc (CSE:VPH) said Thursday that it has received a natural product licence approval from Health Canada authorizing the sale of its for its unique citrus bioflavonoid formulation Hesperco in Canada. "With the  receipt of Health Canada's approval, we are now proceeding with the commercial launch of Hesperco capsules and are anticipating product availability by end of September 2020," Valeo Pharma CEO Steve Saviuk said in a statement. "Hesperco capsules will be available in major health care retailers across the country as well as through our dedicated website, www.hesperco.com, which is currently accepting pre-launch orders,” he added. First Mining Gold Corp (TSE:FF) (OTCQX:FFMGF) revealed that its partner at the Pickle Crow gold project in Ontario has increased the scope of its current drill program to 45,000 metres (m) from 10,000m to boost efforts to expand the resource there. Auteco Minerals, which can earn up to 80% of the asset, currently has two diamond drill rigs turning with a third expected to be mobilized in late September following initial observations, First Mining said in a statement. So far, around 4,500 metres have been completed. "Reconnaissance exploration drilling has resulted in three new, high-grade gold discoveries/extensions already, with significant step-out mineralization returned from Vein 5 extensions, Vein 11 extensions including a new footwall discovery, and a new Vein 112," First Mining said in a statement. Heritage Cannabis Holdings Corp (CSE:CANN) (OTC:HERTF) announced Thursday that its products will soon be available in British Columbia through their Liquor Distribution Branch (LDB) and in Manitoba initially through select licensed retail locations. Both the group's Purefarma and Pura Vida brand vape cartridge products are ready to ship and are expected to be available in these markets in September. Heritage has already received orders for various products, the company said. The British Columbia LDB will carry all seven of Heritage’s vape cartridge products, including Pura Vida CBD 4:1 Honey Oil; Indica, Sativa and Hybrid Honey Oil vape cartridges, and Purefarma Moon, Sun and Earth vape cartridges. In Manitoba, consumers will be able to purchase Purefarma CBD Earth, as well as Pura Vida’s Indica, Sativa, and Hybrid Honey Oil vape cartridges. Ximen Mining Corp (CVE:XIM) (OTCQB:XXMMF) said it has made further progress on the new portal at its historic Kenville gold mine in British Columbia, where excavation has now been completed. The firm has also finished constructing the new steel sets that will be installed underground at the 257 level before positioning a new steel culvert outside the underground workings. "When everything is installed, we will be ready to start breaking rock," the resource group said in a brief statement on Tuesday. Innocan Pharma Corporation (CSE:INNO) announced Thursday that Mackie Research Capital Corporation's institutional sales group has issued an updated Enterprise report on the company. The Enterprise report provides valuable insight into companies that embody value-add for investors, have distinguished themselves among their peers and are bringing innovative and creative ideas into action. In a statement, Innocan said Mackie Research analyst Toby Ma highlighted the Israeli company’s potential clinical, licensing and commercial catalysts. Trace Technologies Inc (CSE:TTT) (OTCMKTS:TTTSF) said it has issued subordinated secured convertible debentures worth $360,000. The firm recently launched a new real-world implementation of its StrainSecure platform with Canada’s largest pharmacy chain Shoppers Drug Mart. The terms of the debenture include a maturity date of three years from the date of issue, with the principal amount payable on the maturity date unless converted earlier. Each debenture bears an interest rate of 8.25% per year payable monthly in arrears. The principal amount of each debenture is convertible into units of TruTrace at a price of $0.05 per debenture unit, with each unit consisting of one share and one whole warrant exercisable at $0.05 for a two-year period. Predictmedix Inc (CSE:PMED) (OTCQB:PMEDF) announced Thursday that its coronavirus-screening technology developed with Juiceworks Exhibits will be utilized at the International Facility Management Association’s (IFMA) 40th World Workplace event in December. Predictmedix has created proprietary safe entry stations that utilize artificial intelligence technology to screen for infectious diseases such as the coronavirus (COVID-19) and display the results in seconds. The technology is designed to mass screen for symptomatic individuals to help reduce the risk of transmission in places which have a large movement of people. Canada Silver Cobalt Works Inc (CVE:CCW) (OTCMKTS:CCWOF) said it has increased and closed on an additional $50,000 in its private placement, bringing the total funds raised in all tranches to $6.74 million. The company said it has issued an additional 90,909 units in the final closing, with each unit comprised of one share and one share purchase warrant exercisable at $0.65 per share. The additional funds follow the closure of the second and final tranche of its private placement financing, with the first and second tranches raising a total of $6.69 million. The company said the proceeds of the private placement will be used for ongoing drilling of the Castle East Robinson Zone discovery near the town of Gowganda, Ontario, as well as for general working capital. Phunware, Inc. (NASDAQ:PHUN), the fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, announced that it has received the Expertise Award as one of the best mobile application developers in Austin. Every month, Expertise helps connect over 10 million customers to leading companies using a proprietary research and selection process to identify experts in over 200 different industries across the top cities in the United States. To select the very best mobile application development companies in Austin, Expertise analyzed and scored 48 companies on more than 25 variables across five categories to include reputation, credibility, experience, availability and professionalism. “This kind of endorsement underscores our commitment to building and licensing the mobile software necessary for any brand to deliver on their mission-critical digital transformation initiatives,” said Alan S. Knitowski, president, CEO and Co-Founder of Phunware. “To win in this new era of mobile, brands have to take a platform approach to mobile application development that enables the deployment of comprehensive mobile app portfolios that are optimized for engagement by industry while also seamlessly integrating with both data in the virtual world and IoT infrastructure in the physical world.” American Battery Metals Corporation (OTCQB:ABML), an American-owned lithium-ion battery recycling and advanced extraction technology company with valuable mineral resources in Nevada, has provided a video link and discuss the Company's ceremonial ground breaking celebration last week in Fernley, Nevada. To view the video: https://www.accesswire.com/users/newswire/images/604621/53bb8dd0-2db1-40c6-a344-db3597c7cdd6.png. "It was great to finally put the shovel in the ground," said American Battery Metals Corporation chief executive officer Doug Cole. "We've worked diligently to get to this point, and we are just getting started. We were honored by such an outpouring of local support from the City of Fernley and Lyon County, including the participation of Fernley Mayor Roy Edgington and Nevada Congressman Mark Amodei. We know we made the right choice in selecting Fernley for this plant." Amodei, the United States Representative for Nevada's 2nd District, is the lead sponsor of H.R. 520, the National Strategic and Critical Minerals Production Act. H.R. 520 seeks to "develop domestic sources of the minerals and mineral materials of strategic and critical importance to the economic and national security and manufacturing competitiveness of the United States." TRACON Pharmaceuticals (NASDAQ:TCON), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost-efficient, CRO-independent product development platform to partner with ex-US. companies to develop and commercialize innovative products in the US, has announced that Charles Theuer, its president and CEO, will present a corporate overview at the 2020 Wells Fargo Virtual Healthcare Conference on Wednesday, September 9, 2020, at 10.40am EDT. To access a live webcast of the presentation, investors can visit the “Events and Presentations” page within the “Investors” section of the TRACON Pharmaceuticals website at www.traconpharma.com. Nemaura Medical, Inc. (NASDAQ:NMRD), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT, its non-invasive and flexible continuous glucose monitor (CGM), together with BEAT diabetes, a planned health subscription service designed to help people with Type 2 diabetes and prediabetes through personalized lifestyle coaching, has announced that its CEO Dr Faz Chowdhury will be presenting at the LD 500 investor conference on Thursday, September 3, 2020 at 10.20am ET. In the presentation, Dr Chowdhury will provide insight into the company’s progress on product rollouts in the USA, Germany and UK, as well as the use of its CGM and lactate monitoring solutions for monitoring of disease progression in COVID-19 patients. Dr Chowdhury will provide further details of the planned launch later this year of the proBEAT product in the USA. Register here: https://ld500.ldmicro.com/ OTC Markets Group Inc. (OTCQX:OTCM), the operator of financial markets for over 11,000 US and global securities, has announced that Regulus Resources Inc. (CVE:REG) (OTCQX:RGLSF), a Canadian mineral exploration company with operations in Peru, has qualified to trade on the OTCQX Best Market. Trading on the OTCQX Market offers companies efficient, cost-effective access to the US capital markets. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. John Black, chief executive officer of Regulus, commented: "As Regulus continues to grow, so too does our shareholder base. We are very pleased to be trading on the OTCQX which will increase our visibility and accessibility to our current and prospective U.S. and global shareholders." Avalon GloboCare Corp (NASDAQ:AVCO), a clinical-stage developer of cell-based technologies and therapeutics, announced that CEO Dr David Jin will participate on a virtual panelentitled, “New Approaches to COVID-19: Hidden Breakthroughs,” to be held September 10 at pm ET. The virtual panel discussion will also include: Tom Equels, CEO of AIM ImmunoTech Inc (NYSEAMERICAN:AIM); Jeff Wolf, CEO of Heat Biologics Inc ( (NASDAQ:HTBX); Dr Jennifer Bath, CEO of ImmunoPrecise Antibodies Ltd (CVE:IPA) (OTCQB:IPATF); and Vered Caplan, CEO of Oregenisis Inc (NASDAQ:ORGS). The event brings together executives from leading biopharmaceutical companies to discuss how their companies are helping address the COVID-19 pandemic. The panel will be moderated by broadcast journalist Christine Corrado of Proactive Investors. Those interested in attending the event can register at https://zoom.us/webinar/register/8215990551540/WN_YFe8n6dQSm6mpgG3iWfF-w